Synthesis, Crystal Structure and Antitumor Activity of N-(4-tert-butyl-5-(4-chlorobenzyl)thiazol-2-yl)-2,6-difluorobenzamide

SHEN Kun PENG Jun-Mei LI Wan YAN Xiao-Wei HU Ai-Xi

Citation:  SHEN Kun, PENG Jun-Mei, LI Wan, YAN Xiao-Wei, HU Ai-Xi. Synthesis, Crystal Structure and Antitumor Activity of N-(4-tert-butyl-5-(4-chlorobenzyl)thiazol-2-yl)-2,6-difluorobenzamide[J]. Chinese Journal of Structural Chemistry, 2014, 33(6): 855-858. shu

Synthesis, Crystal Structure and Antitumor Activity of N-(4-tert-butyl-5-(4-chlorobenzyl)thiazol-2-yl)-2,6-difluorobenzamide

    通讯作者: HU Ai-Xi,
  • 基金项目:

    Project supported by the National Technology R&D Program (No. 2011 BAE06B01) (No. 2011 BAE06B01)

摘要: The title compound was synthesized by the reaction of 4-tert-butyl-5-(4-chlorobenzyl)-2-aminothiazole with 2,6-difluorobenzoic acid. The crystal structure of the title compound, C21H19ClF2N2OS, was determined by single-crystal X-ray diffraction. The crystal belongs to the triclinic system, space group Pbca with a=12.6479(13), b=13.1204(13), c=14.1341(15)Å, Z=4, V=2011.5(4)Å3, Mr=420.89, Dc=1.390 g/cm3, S=1.023, μ=0.326 mm-1, F(000)=872, the final R=0.0365 and wR=0.0880 for 6101 observed reflections (I>2σ(I)), and R=0.0507, wR=0.0978 for 7779 independent reflections. X-ray crystal structure displays that the hydrogen bonding interactions observed link the molecules to form a dimeric unit. The preliminary biological test of the title compound shows good antitumor activity, with IC50 of 0.046 μmol/mL against the Hela cell line.

English

  • 
  • 加载中
计量
  • PDF下载量:  0
  • 文章访问数:  1025
  • HTML全文浏览量:  5
文章相关
  • 收稿日期:  2013-11-28
  • 网络出版日期:  2014-03-06
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

/

返回文章